~~<i id='75E828910E'><strike id='75E828910E'><tt id='75E828910E'><pre id='75E828910E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：hotspot 2025-09-30 16:24:22 - browse：18

Calling Bullshit course University of Washington — Screenshot via callingbullshit.org

Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

The class website and colorful syllabus went online last month and almost instantly went viral.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Illumina names Agilent executive as new CEO

hotspot

focus

hotspot

entertainment

leisure time

JustinKlee,left,andJoshuaCohen,bothco-foundersandco-CEO'sofAmylyxPharmaceuticals.KayanaSzymczakforST

WSS

A rare thyroid diagnosis led to unexpected, all

A new House health package & hospitals’ new site

RaDonda Vaught to speak at CommonSpirit event on patient safety

Crinetics acromegaly drug succeeds in late

Medical device lobby: We're tired of waiting on Medicare coverage

'Make People Better': The CRISPR babies story you probably don't know

explore

knowledge

hotspot

Bright Health sells Medicare Advantage business to Molina

Illumina names Agilent executive as new CEO

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why Novartis is changing the name of its research labs

New air purifier tech could be key to improving indoor air quality

NIH nominee Bertagnolli will get October confirmation hearing

Malaria cases in Florida and Texas: Here’s what you need to know

Why Novartis is changing the name of its research labs

Hepatitis C has a cure — but many Americans still lack access to it

'Make People Better': The CRISPR babies story you probably don't know

focus

What drug price negotiations mean for Medicare Part D

The 10 drugs up first for Medicare price negotiation

FogPharma raises $145 million in rare Series E round

Weighted lottery helped low

FDA does about

Advances in CAR

hotspot

hotspot

entertainment

leisure time